Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Drug & Gene Delivery Devices Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence rate of cardiovascular disorders (CVDs) and lifestyle disorders
5.1.1.2. Introduction of auto-injectors and advanced pulmonary devices
5.1.1.3. Rise in the consumption of drugs and therapeutic pharmaceuticals
5.1.2. Restraints
5.1.2.1. Increase in complications and expertise required in delivering therapeutics and drugs
5.1.3. Opportunities
5.1.3.1. Advancements in the field of drug and gene delivery systems such as smart nanoparticle technology, liposomes & hydrogels, and three-dimensional printing
5.1.3.2. Increasing ongoing research and development in the field of genomics for the development of gene delivery systems
5.1.4. Challenges
5.1.4.1. Increasing cost of high-end products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Drug & Gene Delivery Devices Market, by Route of Administration
6.1. Introduction
6.2. Inhalation
6.3. Injectable
6.4. Nasal
6.5. Ocular
6.6. Oral
6.7. Topical
6.8. Transdermal

7. Drug & Gene Delivery Devices Market, by Method
7.1. Introduction
7.2. Ex vivo
7.3. In situ

8. Drug & Gene Delivery Devices Market, by Vector
8.1. Introduction
8.2. Non-viral
8.3. Viral

9. Americas Drug & Gene Delivery Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Drug & Gene Delivery Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Drug & Gene Delivery Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Antares Pharma, Inc.
13.1.3. B. Braun SE
13.1.4. Baxter International Inc.
13.1.5. Becton, Dickinson and Company
13.1.6. Eisai Co., Ltd.
13.1.7. Enable Injections, Inc.
13.1.8. Gerresheimer AG
13.1.9. Insulet Corporation
13.1.10. Johnson & Johnson Services Inc.
13.1.11. Koninklijke Philips N.V.
13.1.12. Merck KGaA
13.1.13. OraSure Technologies, Inc.
13.1.14. Oxford BioMedica PLC
13.1.15. Sanofi S.A.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. DRUG & GENE DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2022 VS 2030
FIGURE 3. DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. DRUG & GENE DELIVERY DEVICES MARKET DYNAMICS
FIGURE 7. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 8. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
FIGURE 10. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2022 VS 2030 (%)
FIGURE 12. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. DRUG & GENE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. DRUG & GENE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. DRUG & GENE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 6. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 14. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY EX VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY IN SITU, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 17. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY NON-VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 29. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 31. CANADA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 32. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 34. MEXICO DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 46. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 48. CHINA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 49. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 51. INDIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 55. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 57. JAPAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 73. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 75. THAILAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 85. DENMARK DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 86. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 88. EGYPT DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 89. FINLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 91. FINLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 92. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 94. FRANCE DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 95. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 97. GERMANY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 101. ITALY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 103. ITALY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 110. NORWAY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 112. NORWAY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 113. POLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 115. POLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 116. QATAR DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 118. QATAR DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 128. SPAIN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 130. SPAIN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 137. TURKEY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 139. TURKEY DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2018-2030 (USD MILLION)
TABLE 146. DRUG & GENE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 147. DRUG & GENE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 148. DRUG & GENE DELIVERY DEVICES MARKET LICENSE & PRICING